Project Details
Description
A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY OF AG-013736 VERSUS SORAFENIB IN PATIENTS WITH METASTATIC RENAL CELL CANCER FOLLOWING FAILURE OF ONE PRIOR THERAPY
| Status | Finished |
|---|---|
| Effective start/end date | 3/12/08 → 6/30/14 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.